OptiNose, Inc. (OPTN) Financial Statements (2023 and Earlier)

Company Profile

Business Address 1020 STONY HILL ROAD
YARDLEY, PA 19067
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments110,502144,156147,144201,011234,854
Cash and cash equivalents110,502144,156147,144201,011234,854
Receivables35,44923,39413,64324246
Inventory, net of allowances, customer advances and progress billings11,8479,0423,4847,1322,013
Inventory11,8479,0423,4847,1322,013
Other current assets2,5814,0603,6142,1831,254
Other undisclosed current assets  1752,289 
Total current assets:160,379180,652168,060212,857238,167
Noncurrent Assets
Property, plant and equipment1,3472,0283,0523,8842,564
Other noncurrent assets4,3456,1331,538248405
Total noncurrent assets:5,6928,1614,5904,1322,969
TOTAL ASSETS:166,071188,813172,650216,989241,136
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities57,14150,06435,00425,53714,591
Accounts payable8,0135,4893,6257,1165,893
Accrued liabilities49,12844,57531,37918,4218,698
Deferred revenue and credits186
Contract with customer, liability160
Other liabilities2,0942,1081,135  
Total current liabilities:59,23552,17236,13925,69714,777
Noncurrent Liabilities
Long-term debt and lease obligation126,418125,20274,92872,50071,863
Long-term debt, excluding current maturities126,418125,20274,53172,50071,863
Operating lease, liability  397
Liabilities, other than long-term debt2,190    
Other liabilities2,190    
Other undisclosed noncurrent liabilities 4,651 181 
Total noncurrent liabilities:128,608129,85374,92872,68171,863
Total liabilities:187,843182,025111,06798,37886,640
Stockholders' equity
Stockholders' equity attributable to parent(21,772)6,78861,583118,611154,496
Common stock8253464138
Additional paid in capital588,288534,585489,565436,554365,838
Accumulated other comprehensive loss(81)(85)(48)(57)(111)
Accumulated deficit(610,061)(527,765)(427,980)(317,927)(211,269)
Total stockholders' equity:(21,772)6,78861,583118,611154,496
TOTAL LIABILITIES AND EQUITY:166,071188,813172,650216,989241,136

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues74,65249,11734,6317,065162
Revenue, net162
Cost of revenue(9,451)(7,520)(5,294)(1,588) 
Cost of goods and services sold(9,151)(7,520)(5,294)(1,588) 
Gross profit:65,20141,59729,3375,477162
Operating expenses(131,651)(128,816)(124,938)(105,717)(48,530)
Other undisclosed operating loss    (162)
Operating loss:(66,450)(87,219)(95,601)(100,240)(48,530)
Nonoperating income524422,3262,405376
Investment income, nonoperating524262,3592,453303
Foreign currency transaction gain (loss), before tax 16(33)(48)73
Interest and debt expense(15,973)(13,008)(16,778)(9,229)(910)
Other undisclosed income from continuing operations before equity method investments, income taxes   406162
Loss from continuing operations before equity method investments, income taxes:(82,371)(99,785)(110,053)(106,658)(48,902)
Other undisclosed income from continuing operations before income taxes75    
Net loss attributable to parent:(82,296)(99,785)(110,053)(106,658)(48,902)
Preferred stock dividends and other adjustments    (13,065)
Net loss available to common stockholders, diluted:(82,296)(99,785)(110,053)(106,658)(61,967)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(82,296)(99,785)(110,053)(106,658)(48,902)
Comprehensive loss:(82,296)(99,785)(110,053)(106,658)(48,902)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent4(37)954(12)
Comprehensive loss, net of tax, attributable to parent:(82,292)(99,822)(110,044)(106,604)(48,914)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: